Authors
Loading...
Reduced quinidine potency on pediatric I_to may explain lower antiarrhythmic efficacy in children; leaves open age-specific dosing trials.
Key points are not available for this paper at this time.
Nenov et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: